Recent findings from a multi-state study reveal that the RSV vaccine is approximately 80% effective in preventing severe respiratory illnesses in adults over 60, significantly reducing hospitalizations and deaths. The research, which underscores the vaccine’s efficacy during its first U.S. season, suggests substantial health system savings by decreasing RSV-related hospitalizations. RSV Vaccine Effectiveness A multi-state […]
Source link